Provided by Tiger Trade Technology Pte. Ltd.

Regeneron Pharmaceuticals

834.04
+7.400.90%
Post-market: 834.040.00000.00%19:58 EDT
Volume:786.92K
Turnover:656.91M
Market Cap:85.87B
PE:20.63
High:847.00
Open:835.74
Low:826.64
Close:826.64
52wk High:847.00
52wk Low:541.00
Shares:102.95M
Float Shares:98.88M
Volume Ratio:1.27
T/O Rate:0.80%
Dividend:3.64
Dividend Rate:0.44%
EPS(TTM):40.43
EPS(LYR):41.48
ROE:14.04%
ROA:6.53%
PB:2.71
PE(LYR):20.11

Loading ...

Infinimmune Raises $75 Million Series a Financing to Advance Pipeline of Human-Derived Antibodies for Atopic Dermatitis and Inflammatory Disease

Reuters
·
Aug 11

Infinimmune: $75 Mln Series a Financing Co-Led by Regeneron Ventures and Playground Global

THOMSON REUTERS
·
Aug 11

Regeneron Pharmaceuticals Inc. Stock Outperforms Competitors on Strong Trading Day

Dow Jones
·
Aug 11

Movement Alert|Regeneron Pharmaceuticals Rises 3.01% in Regular Trading, Multiple Catalysts Boost Sentiment

Market Focus
·
Aug 11

Regeneron Pharmaceuticals Inc. Stock Outperforms Competitors on Strong Trading Day

Dow Jones
·
Aug 08

Sanofi, Regeneron Seem Keen to Keep Working Together

Dow Jones
·
Aug 07

Regeneron Posts Transcript of Q2 2026 Earnings Conference Call

Reuters
·
Aug 07

Regeneron Canada Says Libtayo Receives Health Canada Approval for Treatment of a Type of Carcinoma

Reuters
·
Aug 06

Regeneron announces Health Canada approval of new indication for Libtayo

TIPRANKS
·
Aug 06

Regeneron Canada: Libtayo Receives Health Canada Approval for Adjuvant Treatment of High-Risk Cutaneous Squamous Cell Carcinoma

THOMSON REUTERS
·
Aug 06

Intellia Therapeutics Q2 Collaboration Revenue Falls, Net Loss Widens

Reuters
·
Aug 06

Intellia Q2 FY26 Net Loss Widens to $106.63 Million; Revenue Falls to $7.66 Million

Reuters
·
Aug 06

Regeneron Pharmaceuticals Inc. Stock Underperforms Wednesday When Compared to Competitors Despite Daily Gains

Dow Jones
·
Aug 06

Wall Street Warms to Healthcare Stocks as Tech Trade Faces Turbulence

Reuters
·
Aug 05

Does Regeneron (REGN) Prioritize Shareholder Returns Over Earnings Quality As Profit Slips Amid Rising Sales?

Simply Wall St.
·
Aug 04

Fujian Haixi Pharma Wins FDA IND Clearance for Hx9428 Phase II nAMD Trial

Reuters
·
Aug 04

Regeneron Pharma is Maintained at Buy by Guggenheim

Dow Jones
·
Aug 03

Achieve Life Sciences Names Ronald Dadino SVP of CMC and Supply Chain

Reuters
·
Aug 03

Regeneron Pharmaceuticals (REGN) Posts Strong Q2 Revenue, Is The Upside Already Priced In?

Simply Wall St.
·
Aug 03

Regeneron price target raised to $740 from $700 at Citi

TIPRANKS
·
Aug 03